Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Montgomery, Jennifer P ^a   Patterson, Paul H ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1,3 BENZODIOXOL 5 YL) 1 [(2,6 DIETHYLPHENYL)CARBAMOYLMETHYL] 2 (4 PROPOXYPHENYL) 3 PYRROLIDINECARBOXYLIC ACID; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; SMALL INTERFERING RNA; CIPROFLOXACIN; DRUG DERIVATIVE; ENDOTHELIN A RECEPTOR; PYRROLIDINE DERIVATIVE; WM5 COMPOUND;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DIVISION; CELL LABELING; CELL PROLIFERATION; CELL VIABILITY; CELLULAR STRESS RESPONSE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DRUG CYTOTOXICITY; DRUG POTENCY; FLUORESCENCE ACTIVATED CELL SORTER; GENE EXPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; MELANOMA CELL; MICROARRAY ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; CELL CYCLE; CELL SURVIVAL; DNA MICROARRAY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; MELANOMA; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CIPROFLOXACIN; DNA DAMAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MELANOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PYRROLIDINES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RNA, SMALL INTERFERING;

EID: 58149330356     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-354     Document Type: Article

References (41)

1. Levin ER: Endothelins. N Engl J Med 1995, 333(6):356-363. 10.1056/ NEJM199508103330607 7609754
2. Nelson J BagnatE A Battistini B Nisen P: The endothelin axis: emerging role in cancer. Nat Rev Cancer 2003, 3(2):110-116. 10.1038/nrc990 12563310
3. Bagnato A Salani D Di Castro V Wu-Wong JR Tecce R Nicotra MR Venuti A Natali PG: Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: Evidence for an autocrine role in tumor growth. Cancer Res 1999, 59(3):720-727. 9973223
4. Kitagawa N Tsutsumi K Niwa M Himeno A Yamashita K Shibata S Taniyama K Kurihara M Kawano T Yasunaga A: Expression of a functional endothelin (ETA) receptor in human meningiomas. J Neurosurg 1994, 80(4):723-731. 8151353
5. Pagotto U Arzberger T Hopfner U Sauer J Renner U Newton CJ Lange M Uhl E Weindl A Stalla GK: Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growth. J Clin Invest 1995, 96(4):2017-2025. 185840 7560095 10.1172/JCI118249
6. Nelson JB Chan-Tack K Hedican SP Magnuson SR Opgenorth TJ Bova GS Simons JW: Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res 1996, 56(4):663-668. 8630991
7. Kikuchi K Nakagawa H Kadono T Etoh T Byers HR Mihm MC Tamaki K: Decreased ET(B) receptor expression in human metastatic melanoma cells. Biochem Biophys Res Commun 1996, 219(3):734-739. 10.1006/bbrc.1996.0303 8645250
8. Eberle J Fecker LF Orfanos CE Geilen CC: Endothelin-1 decreases basic apoptotic rates in human melanoma cell lines. J Invest Dermatol 2002, 119(3):549-555. 10.1046/j.1523-1747.2002.01848.x 12230494
9. Salani D Di Castro V Nicotra MR Rosano L Tecce R Venuti A Natali PG Bagnato A: Role of endothelin-1 in neovascularization of ovarian carcinoma. Am J Pathol 2000, 157(5):1537-1547. 1885720 11073813
10. Spinella F Rosano L Di Castro V Natali PG Bagnato A: Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells. J Biol Chem 2002, 277(31):27850-27855. 10.1074/jbc.M202421200 12023962
11. Rosano L Salani D Di Castro V Spinella F Natali PG Bagnato A: Endothelin-1 promotes proteolytic activity of ovarian carcinoma. Clin Sci (Lond) 2002, 103(Suppl 48):306S-309S. 12193110
12. Rosano L Varmi M Salani D Di Castro V Spinella F Natali PG Bagnato A: Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells. Cancer Res 2001, 61(22):8340-8346. 11719468
13. Bagnato A Rosano L Spinella F Di Castro V Tecce R Natali PG: Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression. Cancer Res 2004, 64(4):1436-1443. 10.1158/0008-5472.CAN-03-2344 14973117
14. Naidoo V Naidoo S Mahabeer R Raidoo DM: Localization of the endothelin system in human diffuse astrocytomas. Cancer 2005, 104(5):1049-1057. 10.1002/cncr.21277 16007684
15. Takahashi K Totsune K Kitamuro T Sone M Murakami O Shibahara S: Three vasoactive peptides, endothelin-1, adrenomedullin and urotensin-II, in human tumour cell lines of different origin: Expression and effects on proliferation. Clin Sci (Lond) 2002, 103(Suppl 48):35S-38S. 12193050
16. Sone M Takahashi K Totsune K Murakami O Arihara Z Satoh F Mouri T Shibahara S: Expression of endothelin-1 and endothelin receptors in cultured human glioblastoma cells. J Cardiovasc Pharmacol 2000, 36(5 Suppl 1):S390-392. 11078429
17. Stiles JD Ostrow PT Balos LL Greenberg SJ Plunkett R Grand W Heffner RR Jr: Correlation of endothelin-1 and transforming growth factor beta 1 with malignancy and vascularity in human gliomas. J Neuropathol Exp Neurol 1997, 56(4):435-439. 10.1097/00005072-199704000-00012 9100674
18. Harland SP Kuc RE Pickard JD Davenport AP: Expression of endothelin(A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707. Neurosurgery 1998, 43(4):890-898. 10.1097/ 00006123-199810000-00097 9766317
19. Egidy G Eberl LP Valdenaire O Irmler M Majdi R Diserens AC Fontana A Janzer RC Pinet F Juillerat-Jeanneret L: The endothelin system in human glioblastoma. Lab Invest 2000, 80(11):1681-1689. 10.1038/ labinvest.3780178 11092528
20. Berger Y Dehmlow H Blum-Kaelin D Kitas EA Loffler BM Aebi JD Juillerat-Jeanneret L: Endothelin-converting enzyme-1 inhibition and growth of human glioblastoma cells. J Med Chem 2005, 48(2):483-498. 10.1021/jm040857x 15658862
21. He S Dibas A Yorio T Prasanna G: Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells. Exp Biol Med (Maywood) 2007, 232(3):370-384. 17327470
22. Lahav R Heffner G Patterson PH: An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo. Proc Natl Acad Sci USA 1999, 96(20):11496-11500. 18062 10500205 10.1073/pnas.96.20.11496
23. Wu-Wong JR Dixon DB Chiou WJ Sorensen BK Liu G Jae HS Tasker A von Geldern TW Winn M Opgenorth TJ: Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: In vitro studies. Clin Sci (Lond) 2002, 103(Suppl 48):107S-111S. 12193066
24. Ishikawa K Ihara M Noguchi K Mase T Mino N Saeki T Fukuroda T Fukami T Ozaki S Nagase T: Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA 1994, 91(11):4892-4896. 43895 8197152 10.1073/pnas.91.11.4892
25. Takekawa M Saito H: A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 1998, 95(4):521-530. 10.1016/S0092-8674(00)81619-0 9827804
26. Jin S Tong T Fan W Fan F Antinore MJ Zhu X Mazzacurati L Li X Petrik KL Rajasekaran B: GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity. Oncogene 2002, 21(57):8696-8704. 10.1038/sj.onc.1206034 12483522
27. Wang XW Zhan Q Coursen JD Khan MA Kontny HU Yu L Hollander MC O'Connor PM Fornace AJ Jr Harris CC: GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci USA 1999, 96(7):3706-3711. 22358 10097101 10.1073/pnas.96.7.3706
28. Zhan Q Antinore MJ Wang XW Carrier F Smith ML Harris CC Fornace AJ Jr: Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene 1999, 18(18):2892-2900. 10.1038/sj.onc.1202667 10362260
29. Jin S Antinore MJ Lung FD Dong X Zhao H Fan F Colchagie AB Blanck P Roller PP Fornace AJ Jr: The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression. J Biol Chem 2000, 275(22):16602-16608. 10.1074/jbc.M000284200 10747892
30. Hollander MC Zhan Q Bae I Fornace AJ Jr: Mammalian GADD34, an apoptosis- and DNA damage-inducible gene. J Biol Chem 1997, 272(21):13731-13737. 10.1074/jbc.272.21.13731 9153226
31. Zhan Q Lord KA Alamo I Jr Hollander MC Carrier F Ron D Kohn KW Hoffman B Liebermann DA Fornace AJ Jr: The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol Cell Biol 1994, 14(4):2361-2371. 358603 8139541
32. Adler HT Chinery R Wu DY Kussick SJ Payne JM Fornace AJ Jr Tkachuk DC: Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins. Mol Cell Biol 1999, 19(10):7050-7060. 84700 10490642
33. Matsumoto M Minami M Takeda K Sakao Y Akira S: Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells. FEBS Lett 1996, 395(2-3):143-147. 10.1016/0014-5793(96)01016-2 8898082
34. Peeters H Debeer P Bairoch A Wilquet V Huysmans C Parthoens E Fryns JP Gewillig M Nakamura Y Niikawa N: PA26 is a candidate gene for heterotaxia in humans: Identification of a novel PA26-related gene family in human and mouse. Hum Genet 2003, 112(5-6):573-580. 12607115
35. Velasco-Miguel S Buckbinder L Jean P Gelbert L Talbott R Laidlaw J Seizinger B Kley N: PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes. Oncogene 1999, 18(1):127-137. 10.1038/sj.onc.1202274 9926927
36. Budanov AV Shoshani T Faerman A Zelin E Kamer I Kalinski H Gorodin S Fishman A Chajut A Einat P: Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability. Oncogene 2002, 21(39):6017-6031. 10.1038/sj.onc.1205877 12203114
37. Sheridan JP Marsters SA Pitti RM Gurney A Skubatch M Baldwin D Ramakrishnan L Gray CL Baker K Wood WI: Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997, 277(5327):818-821. 10.1126/science.277.5327.818 9242611
38. Pan G Ni J Wei YF Yu G Gentz R Dixit VM: An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997, 277(5327):815-818. 10.1126/science.277.5327.815 9242610
39. Walczak H Degli-Esposti MA Johnson RS Smolak PJ Waugh JY Boiani N Timour MS GArhart MJ Schooley KA Smith CA: TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J 1997, 16(17):5386-5397. 1170170 9311998 10.1093/emboj/16.17.5386
40. Nagane M Pan G Weddle JJ Dixit VM Cavenee WK Huang HJ: Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. Cancer Res 2000, 60(4):847-853. 10706092
41. Lahav R Suva M-L Rimoldi D Patterson PH Stamenkovic I: Endothelin receptor B inhibition triggers apoptosis and enhances antiogenesis in melanomas. Cancer Res 2004, 64:8945-8953. 10.1158/0008-5472.CAN-04-1510 15604257